Marc J. Dinkin, MD


Conditions Treated:

Marc J. Dinkin

About Me

I am a neuro-ophthalmologist with a special interest in the neuro-ophthalmic complications of cancer and brain tumors; including vision loss, double vision, nystagmus (shaking of the eyes), and pupil changes. I am the director of neuro-ophthalmology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and have the privilege of performing neuro-ophthalmological consultations for patients at Memorial Sloan Kettering Cancer Center. My research interests include the effects of cancer, and especially leptomeningeal disease, on the optic nerve and the immune effects of certain cancers (paraneoplastic disease) on the optic nerve and retina.

Read more

Tumors of the pituitary and its surroundings commonly cause vision loss by compressing the optic chiasm or optic nerves, requiring close monitoring of visual function. I am particularly interested in the ability of new technologies such as optical coherence tomography (OCT) to predict whether or not surgical intervention might improve a patient’s vision. I am also interested in papilledema, a swelling of the optic nerves that occurs with elevated head pressure, and its effects on vision in patients with brain tumors. Vision is pivotal to patients’ daily quality of life, and I am committed to doing everything I can to preserve vision for our patients.

  • Clinical Expertise: Neuro-ophthalmology: visual complications of brain tumors, double vision, nystagmus, and pupillary problems related to tumors.
  • Languages Spoken: English
  • Education: MD, Weill Cornell Medical College
  • Residencies: NewYork-Presbyterian Hospital/Weill Cornell Medical College (neurology)
  • Fellowships: Massachusetts Eye and Ear Infirmary (neuro-ophthalmology)
  • Board Certifications: Neurology

New Patient Appointments

Making an appointment

Call 800-525-2225


Visit PubMed for a full listing of Marc J. Dinkin’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more